Interestingly, the homeostatic CCL5 expression from the host’s immune cells has significant impacts on priming functional states of the immune cells at nonimmune tissues, such as lungs, resulting in altered tumor immunity against metastatic cancer. Here, CCL5 is linked to metastatic malignant neoplasm.